- Rage mounts against pharma corp. that jacked cost of life-saving EpiPen by 400% http://arstechnica.com/science/2016/08/rage-mounts-against-pharma-corp-that-jacked-cost-of-life-saving-epipen-by-400/ 81 comments politics
- Rage mounts against pharma corp. that jacked cost of life-saving EpiPen by 400% http://arstechnica.com/science/2016/08/rage-mounts-against-pharma-corp-that-jacked-cost-of-life-saving-epipen-by-400/ 116 comments worldnews
Linking pages
- Feds go after Mylan for scamming Medicaid out of millions on EpiPen pricing | Ars Technica http://arstechnica.com/science/2016/09/feds-go-after-mylan-for-scamming-medicaid-out-of-millions-on-epipen-pricing/ 1459 comments
- Pfizer raises prices on 100 drugs—again—despite backlash from public, lawmakers | Ars Technica https://arstechnica.com/science/2018/07/pfizer-raises-prices-on-100-drugs-again-despite-backlash-from-public-lawmakers/ 643 comments
- FDA slams EpiPen maker for doing nothing while hundreds failed, people died | Ars Technica https://arstechnica.com/science/2017/09/fda-slams-epipen-maker-for-doing-nothing-while-hundreds-failed-people-died/ 159 comments
- CVS just announced a super cheap generic alternative to EpiPen | Ars Technica http://arstechnica.com/science/2017/01/cvs-just-announced-a-super-cheap-generic-alternative-to-epipen/ 102 comments
- Pharma company boosts the price of an old acne cream 3,900% | Ars Technica http://arstechnica.com/science/2016/09/got-acne-and-money-heres-a-possibly-effective-zit-cream-thats-now-10k/ 56 comments
- Lawsuit: Mylan’s epic EpiPen price hike wasn’t about greed—it’s worse | Ars Technica https://arstechnica.com/science/2017/04/lawsuit-mylans-epic-epipen-price-hike-wasnt-about-greed-its-worse/ 54 comments
- Mylan CEO “frustrated” by own price gouging but doesn’t lower EpiPen price | Ars Technica http://arstechnica.co.uk/science/2016/08/mylan-ceo-frustrated-by-own-price-gouging-but-doesnt-lower-epipen-price/ 40 comments
- FDA slams EpiPen maker for doing nothing while hundreds failed, people died | Ars Technica https://arstechnica.co.uk/science/2017/09/fda-slams-epipen-maker-for-doing-nothing-while-hundreds-failed-people-died/ 40 comments
- Despite what Mylan said, its price hikes hit patients’ wallets hard | Ars Technica https://arstechnica.com/science/2017/03/despite-what-mylan-said-its-price-hikes-hit-patients-wallets-hard/ 10 comments
- Ex-pharma execs charged by feds for fixing generic drug prices | Ars Technica http://arstechnica.com/science/2016/12/feds-begin-crackdown-on-generic-drug-price-fixing-nail-two-former-execs/ 8 comments
- Pfizer raises prices on 100 drugs—again—despite backlash from public, lawmakers – Ars Technica https://arstechnica.com/science/2018/07/pfizer-raises-prices-on-100-drugs-again-despite-backlash-from-public-lawmakers/?amp=1 8 comments
- For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million | Ars Technica http://arstechnica.com/science/2016/10/for-ripping-off-medicaid-epipen-maker-mylan-pays-feds-465-million/ 6 comments
- EpiPen maker CEO to seething lawmakers: We’re doing the world a favor | Ars Technica http://arstechnica.com/science/2016/09/epipen-maker-ceo-to-seething-lawmakers-were-doing-the-world-a-favor/ 6 comments
- EpiPen maker Mylan may have used illegal deals with schools to price gouge | Ars Technica http://arstechnica.com/science/2016/09/epipen-maker-mylan-may-have-used-illegal-deals-with-schools-to-price-gouge/ 3 comments
- Amid outrage and tumbling stocks, Mylan’s chairman pocketed $97M | Ars Technica https://arstechnica.com/science/2017/05/amid-outrage-and-tumbling-stocks-mylans-chairman-pocketed-97m/ 0 comments
Linked pages
- Congress Presses Pharmaceutical Company to Explain Surge in Cost of EpiPen - The New York Times http://www.nytimes.com/2016/08/24/us/politics/epipen-mylan-congress.html 581 comments
- Martin Shkreli Weighs in on EpiPen Scandal, Calls Drug Makers 'Vultures' http://www.nbcnews.com/business/consumer/martin-shkreli-weighs-epipen-scandal-calls-drug-makers-vultures-n634451 315 comments
- Controversial CEO in the hot seat over EpiPen price hikes https://www.statnews.com/2016/08/24/epipen-mylan-bresch/ 0 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: Rage mounts against pharma corp. that jacked cost of life-saving EpiPen by 400% | Ars Technica
See how to search.